BenzingaSeptember 18, 2026 at 8:49 AM NYLast Month
Truist Securities Maintains Buy on DexCom, Raises Price Target to $102
Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $93 to $102.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
